title: Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia?
abstract: Thrombocytopenia in cirrhotic patients is usually attributed to splenic pooling whereas in idiopathic thrombocytopenic purpura it is related to platelet bound immunoglobulin (PA-IgG). Since primary biliary cirrhosis (PBC) is an autoimmune disorder we have undertaken a prospective study to assess the frequency and possible relationship of PA-IgG to thrombocytopenia in this condition. Sixty-two primary biliary cirrhosis patients (28 precirrhotic; 34 cirrhotic) were studied. Twenty-five patients (40%) had raised PA-IgG of whom 18 had cirrhosis. There was a significant inverse correlation between platelet count and PA-IgG (p less than 0.001) and between platelet count and spleen size (p less than 0.001). Thrombocytopenia (platelets less than 100 X 10(9)/l) was found in nine patients (15%); all nine had raised PA-IgG and eight were cirrhotic with an enlarged spleen. Two cirrhotic patients with persistent thrombocytopenia and bleeding episodes were treated with prednisolone and showed a useful therapeutic response. These results suggest that immune mediated platelet destruction and splenic pooling of platelets may both play a part in the thrombocytopenia observed in primary biliary cirrhosis.
mesh_terms: D001792:Blood Platelets / Q000276:immunology*; D004844:Epistaxis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis*; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D010976:Platelet Count; D011239:Prednisolone / Q000627:therapeutic use; D011446:Prospective Studies; D013163:Splenomegaly / Q000150:complications; D013921:Thrombocytopenia / Q000209:etiology*
chemical_list: D007074:Immunoglobulin G; D011239:Prednisolone